Neurochemistry and defects of biogenic amine neurotransmitter metabolism.
The purpose of the current review is to present a brief background examining the mechanisms controlling synthesis, storage, release and action of the biogenic amine neurotransmitters and to provide examples of newly defined conditions that expand our awareness of the diversity and complexity of the inherited diseases that affect these important regulators of central and peripheral homeostasis.
Hyland
K
K
Institute of Metabolic Disease, Baylor University Medical Center, Dallas, TX 75226, USA. k.hyland@baylordallas.edu
D001679:Biogenic Amines / Q000096:biosynthesis / Q000378:metabolism* / Q000502:physiology; D015306:Biogenic Monoamines / Q000378:metabolism*; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000378:metabolism
D001679:Biogenic Amines; D015306:Biogenic Monoamines